Effects of a cardiac glycoside on plasma phospholipid levels in man.
D000284:Administration, Oral; D000328:Adult; D000367:Age Factors; D001692:Biological Transport / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D002855:Chromatography, Thin Layer; D004077:Digoxin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008244:Lysophosphatidylcholines / Q000097:blood; D008297:Male; D010713:Phosphatidylcholines / Q000097:blood; D010714:Phosphatidylethanolamines / Q000097:blood; D010743:Phospholipids / Q000097:blood*; D013109:Sphingomyelins / Q000097:blood; D013997:Time Factors
D008244:Lysophosphatidylcholines; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D010743:Phospholipids; D013109:Sphingomyelins; D004077:Digoxin; D002118:Calcium